Document is current
Any future updates will be listed below
-
Authors
Gogishvili, Dea https://orcid.org/0000-0001-8809-0861
Vromen, Eleonora M.
Koppes-den Hertog, Sascha
Lemstra, Afina W.
Pijnenburg, Yolande A. L. https://orcid.org/0000-0003-2464-1905
Visser, Pieter Jelle https://orcid.org/0000-0001-8008-9727
Tijms, Betty M. https://orcid.org/0000-0002-2612-1797
Del Campo, Marta
Abeln, Sanne https://orcid.org/0000-0002-2779-7174
Teunissen, Charlotte E. https://orcid.org/0000-0002-4061-0837
Vermunt, Lisa https://orcid.org/0000-0001-7420-6384
-
Funding
Funding for this research was provided by:
European Commission, Marie Curie International Training Network (860197)
JPND
The Selfridges Group Foundation
Alzheimer Netherlands
attraction talent fellowship of Comunidad de Madrid
I+D+i 2020 projects from the Spanish ministry of science and innovation
Dutch Research Council
Alzheimer Drug Discovery Foundation
Alzheimer Association
Stichting Dioraphte
- License Information
-
More Information
Article History
Received: 15 December 2022
Accepted: 6 April 2023
First Online: 21 April 2023
Competing interests
: CT is the recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and HealthHolland, Topsector Life Sciences and Health (PPP-allowance; #LSHM20106). More than 30 partners participate in ABOARD. ABOARD also receives funding from Edwin Bouw Fonds and Gieskes-Strijbisfonds. CT has a collaboration contract with ADx Neurosciences, Quanterix and Eli Lilly, performed contract research or received grants from AC-Immune, Axon Neurosciences, Biogen, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Olink, PeopleBio, Roche, Toyama, Vivoryon. She serves on editorial boards of Medidact Neurologie/Springer, Alzheimer Research and Therapy, Neurology: Neuroimmunology and Neuroinflammation, and is editor of a Neuromethods book Springer. LV has received grants or consultancy fees from Olink, Roche, ZonMw, Dioraphte and Alzheimer Nederland, paid to her institution. The rest of the authors do not have any competing interest to declare.
